371 related articles for article (PubMed ID: 21689324)
21. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996.
Torres EA; De Jesús R; Pérez CM; Iñesta M; Torres D; Morell C; Just E
P R Health Sci J; 2003 Sep; 22(3):253-8. PubMed ID: 14619451
[TBL] [Abstract][Full Text] [Related]
22. Orthopaedic experience on inflammatory bowel disease (Lesniowski-Crohn's disease and ulcerative colitis).
Geraci A; Tomasello G; Sabetta SP
Ortop Traumatol Rehabil; 2010; 12(5):430-4. PubMed ID: 21057150
[TBL] [Abstract][Full Text] [Related]
23. Progression of low-grade dysplasia in ulcerative colitis: effect of colonic location.
Goldstone R; Itzkowitz S; Harpaz N; Ullman T
Gastrointest Endosc; 2011 Nov; 74(5):1087-93. PubMed ID: 21907984
[TBL] [Abstract][Full Text] [Related]
24. Ulcerative colitis in Stockholm County--a study of epidemiology, prognosis, mortality and cancer risk with special reference to a surveillance program.
Broström O
Acta Chir Scand Suppl; 1986; 534():1-60. PubMed ID: 3472421
[TBL] [Abstract][Full Text] [Related]
25. Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease.
Romberg-Camps MJ; Dagnelie PC; Kester AD; Hesselink-van de Kruijs MA; Cilissen M; Engels LG; Van Deursen C; Hameeteman WH; Wolters FL; Russel MG; Stockbrügger RW
Am J Gastroenterol; 2009 Feb; 104(2):371-83. PubMed ID: 19174787
[TBL] [Abstract][Full Text] [Related]
26. Inflammatory bowel disease as a risk factor for colorectal cancer.
Lukas M
Dig Dis; 2010; 28(4-5):619-24. PubMed ID: 21088413
[TBL] [Abstract][Full Text] [Related]
27. Malignant neoplasms subsequent to treatment of inflammatory bowel disease with 6-mercaptopurine.
Korelitz BI; Mirsky FJ; Fleisher MR; Warman JI; Wisch N; Gleim GW
Am J Gastroenterol; 1999 Nov; 94(11):3248-53. PubMed ID: 10566724
[TBL] [Abstract][Full Text] [Related]
28. Differences in pathogenesis, incidence and outcome of perforation in inflammatory bowel disease.
Greenstein AJ; Aufses AH
Surg Gynecol Obstet; 1985 Jan; 160(1):63-9. PubMed ID: 3871126
[TBL] [Abstract][Full Text] [Related]
29. Increased risk of colorectal cancer and dysplasia in patients with Crohn's colitis and primary sclerosing cholangitis.
Lindström L; Lapidus A; Ost A; Bergquist A
Dis Colon Rectum; 2011 Nov; 54(11):1392-7. PubMed ID: 21979184
[TBL] [Abstract][Full Text] [Related]
30. [Epidemiology of inflammatory bowel diseases in Veszprém county of Western Hungary between 1977 and 2001].
Lakatos L; Mester G; Erdélyi Z; Balogh M; Szipócs I; Kamarás G; Lakatos PL
Orv Hetil; 2003 Sep; 144(37):1819-27. PubMed ID: 14596020
[TBL] [Abstract][Full Text] [Related]
31. Colorectal cancer in colonic Crohn's disease--high frequency of DNA-aneuploidy.
Sjöqvist U; Befrits R; Söderlund S; Ost A; Karlén P; Tribukait B; Rubio C; Rutgeerts P; Geboes K; Löfberg R
Anticancer Res; 2005; 25(6C):4393-7. PubMed ID: 16334114
[TBL] [Abstract][Full Text] [Related]
32. Fistulizing pattern in Crohn's disease and pancolitis in ulcerative colitis are independent risk factors for cancer: a single-center cohort study.
Biancone L; Zuzzi S; Ranieri M; Petruzziello C; Calabrese E; Onali S; Ascolani M; Zorzi F; Condino G; Iacobelli S; Pallone F
J Crohns Colitis; 2012 Jun; 6(5):578-87. PubMed ID: 22398047
[TBL] [Abstract][Full Text] [Related]
33. Does colorectal cancer in ulcerative colitis patients constitute a risk for chemotherapy refractoriness?:a systemic approach by detailed analysis via the electronic tumor base documentation system.
Engelhardt M; Ihorst G; Udi J; Kleber M; Rawluk J; Wäsch R
Onkologie; 2011; 34(12):688-94. PubMed ID: 22156448
[TBL] [Abstract][Full Text] [Related]
34. Clinical features of ulcerative colitis and Crohn's disease in Turkey.
Ozin Y; Kilic MZ; Nadir I; Cakal B; Disibeyaz S; Arhan M; Dagli U; Tunc B; Ulker A; Sahin B
J Gastrointestin Liver Dis; 2009 Jun; 18(2):157-62. PubMed ID: 19565044
[TBL] [Abstract][Full Text] [Related]
35. Crohn's disease and colorectal carcinoma: rectal cancer complicating longstanding active perianal disease.
Nikias G; Eisner T; Katz S; Levin L; Eskries D; Urmacher C; McKinley M
Am J Gastroenterol; 1995 Feb; 90(2):216-9. PubMed ID: 7847288
[TBL] [Abstract][Full Text] [Related]
36. Inflammatory bowel disease in Iran: a review of 457 cases.
Aghazadeh R; Zali MR; Bahari A; Amin K; Ghahghaie F; Firouzi F
J Gastroenterol Hepatol; 2005 Nov; 20(11):1691-5. PubMed ID: 16246187
[TBL] [Abstract][Full Text] [Related]
37. Assessment of colorectal cancer risk in patients with ulcerative colitis: experience from a private practice.
Katzka I; Brody RS; Morris E; Katz S
Gastroenterology; 1983 Jul; 85(1):22-9. PubMed ID: 6852458
[TBL] [Abstract][Full Text] [Related]
38. Dysplasia and cancer in inflammatory bowel disease 10 years after diagnosis: results of a population-based European collaborative follow-up study.
Katsanos KH; Vermeire S; Christodoulou DK; Riis L; Wolters F; Odes S; Freitas J; Hoie O; Beltrami M; Fornaciari G; Clofent J; Bodini P; Vatn M; Nunes PB; Moum B; Munkholm P; Limonard C; Stockbrugger R; Rutgeerts P; Tsianos EV;
Digestion; 2007; 75(2-3):113-21. PubMed ID: 17598963
[TBL] [Abstract][Full Text] [Related]
39. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
Rubin DT; Rothe JA; Hetzel JT; Cohen RD; Hanauer SB
Gastrointest Endosc; 2007 Jun; 65(7):998-1004. PubMed ID: 17451704
[TBL] [Abstract][Full Text] [Related]
40. Early onset of ulcerative colitis: long-term follow-up with special reference to colorectal cancer and primary sclerosing cholangitis.
Lindberg J; Stenling R; Palmqvist R; Rutegård J
J Pediatr Gastroenterol Nutr; 2008 May; 46(5):534-8. PubMed ID: 18493208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
